Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal‐tension glaucoma: the randomized phase II study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal‐tension glaucoma: the randomized phase II study

Published:2021-07-28 Issue:2 Volume:100 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmologica

Author:

Ha Ahnul¹²^ORCID,Kim Young Kook¹³^ORCID,Jeoung Jin Wook¹³^ORCID,Satyal Sanjeev⁴,Kim Jaesoon⁴,Kim Soojin⁴,Park Ki Ho¹³^ORCID

Affiliation:

1. Department of Medicine Seoul National University College of Medicine Seoul Korea

2. Department of Ophthalmology Jeju National University Hospital Jeju‐si Korea

3. Department of Ophthalmology Seoul National University Hospital Seoul Korea

4. pH‐Pharma Co., Ltd Seoul Korea

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.14949

Reference36 articles.

1. Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma

2. Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure

3. Regression to the mean: what it is and how to deal with it

4. Retrometabolic drug design: Principles and recent developments

5. 3-[2-(Aminomethyl)-5-[(pyridin-4-yl)carbamoyl]phenyl] benzoates as soft ROCK inhibitors

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Application of Rho Kinase Inhibitors in the Management of Glaucoma;International Journal of Molecular Sciences;2024-05-21

2. Rho Kinase Inhibitors: Strategies in Glaucoma Treatment in Older Adults;Drugs & Aging;2024-02-28

3. Advances in targeting the extracellular matrix for glaucoma therapy: current updates;Expert Opinion on Therapeutic Targets;2023-12-02

4. Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork;European Journal of Pharmacology;2023-09

5. Pharmaceutical Approaches to Normal Tension Glaucoma;Pharmaceuticals;2023-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3